Loading...
OTCM
TIHE
Market cap0kUSD
Mar 03, Last price  
0.00USD
Name

Taihe Group Inc

Chart & Performance

D1W1MN
No data to show
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
0k
Net income
-44k
L+50.47%
0-29,219-43,967
CFO
-42k
L+43.33%
0-29,219-41,881

Profile

Taihe Group, Inc. does not have significant operations. Previously, it was operated as commercial laboratory and provided predictive chemosensitivity and immunotherapy predictive tests on biopsy tissues and other oncological laboratory testing services and products. The company was formerly known as NuOncology Labs, Inc. and changed its name to Taihe Group, Inc. in April 2022. Taihe Group, Inc. was incorporated in 1994 and is based in Scottsdale, Arizona.
URL
IPO date
Jul 11, 2001
Employees
3
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFY
2022‑122021‑122020‑12
Income
Revenues
Cost of revenue
44
Unusual Expense (Income)
NOPBT
(44)
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
(44)
Net income
(44)
50.47%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
42
Long-term debt
Deferred revenue
Other long-term liabilities
2
Net debt
42
Cash flow
Cash from operating activities
(42)
CAPEX
Cash from investing activities
Cash from financing activities
42
FCF
(42)
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
(10,872)
Invested Capital
10,870
ROIC
ROCE
2,107.72%
EV
Common stock shares outstanding
63
Price
1.56
 
Market cap
98
 
EV
150
EBITDA
(44)
EV/EBITDA
Interest
Interest/NOPBT